|
Date Submitted:
12/11/07
Hits: 16 Rating:  0/5 based on 0 votes
Gout Drug Shows Promise
Description:
A drug called rilonacept (IL-1 Trap) may reduce disease activity and pain in patients with chronic active gout. That's according to a non-randomized, single-blind, placebo-controlled study of 10 patients, average age 62, who had gout for an average of 13 years.
Read the Complete Article Similar content: Hepatitis E Vaccine Shows Promise, in Hepatitis Large Jolts of Java Can Keep Gout at Bay, in Arthritis Soy-Based Inhibitor Holds Promise as MS Treatment, in Multiple Sclerosis New Imaging Techniques Hold Promise for Variety of Diseases, in Alzheimers Genetics Hold Promise, Challenges for Cancer Care, in Leukemia |
